Georgia Medical Marijuana Legislation in 2017

Georgia Medical Marijuana Legislation in 2017

The 2017 Georgia General Assemble began on January 9th.

During the first week of the session, Georgia lawmakers filed three cannabis related bills dealing with Georgia’s medical marijuana system.

We were there on the first day of session and have continued to be present and want to bring you up to date on these pieces of legislation.

House Resolution 36 (HR 36)

Rep. Allen Peake filed House Resolution 36 proposing a Constitutional amendment allowing the public to vote YES or NO on the in-state production and sale of “cannabis medicine” with tax revenue being dedicated to “drug treatment programs” within the state.

The short two page resolution has six initial signors. The summary of the resolution is as follows:

Proposing an amendment to the Constitution so as to authorize the General Assembly to provide by law for the regulation of the production of cannabis and sale of medical cannabis to certain individuals for medical usage as provided by law; to provide that the fees paid from the production of cannabis and state tax proceeds from the sale of medical cannabis be dedicated; to provide that such funds shall not lapse; to provide for submission of this amendment for ratification or rejection; and for other purposes.”

If the resolution passes in the 2017 or 2018 legislative session, the proposed vote would take place in the November 2018 General Election and will look like this:

In State Cultivation Referendum

House Bill 65 (HB 65)

Rep. Peake also filed House Bill 65 which would amend the current “Low THC Oil” law established by HB-1 in 2015. The bill eliminates the requirement that a disease be “severe” and “end stage” and includes additional medical conditions for which cannabis oil can legally be used.

The proposed additional conditions currently include the list below. This list could change if the bill is amended in the process.

  • Tourette’s syndrome
  • Autism spectrum disorder
  • Intractable pain
  • Post-traumatic stress disorder (PTSD)
  • Human immunodeficiency virus (HIV)
  • Acquired immune deficiency syndrome (AIDS)
  • Alzheimer’s disease.

The bill also removes the one year residency requirement for registry of patients and the requirement for doctors to file quarterly reports on patients using the cannabis oil. Both of these represent intentionally restrictive elements to the existing law.

The summary of the bill reads:

“To amend Code Section 31-2A-18 of the Official Code of Georgia Annotated, relating to the establishment of the Low THC Oil Patient Registry, definitions, purpose, registration cards, quarterly reports, and waiver forms, so as to change provisions relating to conditions and eligibility; to provide a definition; to remove certain reporting requirements; to provide for related matters; to repeal conflicting laws; and for other purposes.”

Senate Bill 16 (SB 16)

Senate Bill 16 filed by Senator Watson of the 1st, Senator Unterman of the 45th, and others, reduces the allowed THC in cannabis oil from 5% to 3%. It also adds Autism spectrum disorder to the list of legally treatable conditions.

The bill’s summary:

“To amend Article 8 of Chapter 12 of Title 16 and Code Section 31- 2A-18 of the Official Code of Georgia Annotated, relating to the regulation of low THC oil and the establishment of the Low THC Oil Patient Registry, definitions, purpose, registration cards, quarterly reports, and waiver forms, respectively, so as to change the definition of low THC oil; to change provisions relating to conditions eligible for use of low THC oil; to provide for related matters; to repeal conflicting laws; and for other purposes.”

Our Position

Georgia CARE Project is currently reviewing the legislation and will offer our position in the near future.

Other Legislation?

We anticipate at least one to two additional bills being filed in the coming weeks and we will look forward to updating you on that as soon as it becomes official.

We plan to continue working at the Capitol to communicate to lawmakers that Georgians are ready for reform and that we want to see more compassionate treatment options for patients, caretakers, and doctors alike.

2017 Georgia General Assembly Legislative Session

The 1st day of the 2017 Georgia legislative session.

Georgia CARE Project has lobbied and testified before various committees and met with dozens of legislators over the past several years.

We have established the “40 Days Campaign” to ensure we have our director James Bell working the capitol and meeting with lawmakers each day of the session and to better educate them on why and how we can reform our oppressive state laws.

Georgia Medical Marijuana Reform in 2017:

State Rep. Allen Peake (R-Macon) announced his plans to file legislation seeking a public vote on in-state cultivation of cannabis for medicinal use.

Peake has taken on the medical cannabis issue over the past several years with some success. The successful House Bill 1 allows some patients to use low-THC cannabis oil. However, no legal supply of the medicine was, or is, as of yet, available in Georgia.

As a result, many families are now in the difficult position of having to violate state law in order to import medicine.

Georgia CARE Project (Campaign for Access, Reform and Education) supports a ballot initiative that takes the issue directly to the public, in order to resolve this issue.

According to James Bell, Director of Georgia CARE, the public understands the issue and can make a rational decision on their own.

“We know there is huge support amongst the public and General Assembly”, Bell said. A recent Atlanta Journal Constitution poll found that 71% of Georgians support the expansion of medical marijuana. “They trust us to vote for them each election cycle. Therefore they should trust us to make a decision on the medical cannabis issue.”

Bell points out that Gov. Deal and his floor leaders push back on in-state cultivation, claiming the industries are unable to keep cultivation under control. This is in contrast to the dozens of states that currently produce cannabis. Experience shows us that producers and regulators can effectively track the plant from seed to patient.

Looking Forward

“Both medical cannabis and ‘recreational’ cannabis will be legal. It’s not a matter of if, but when. These are two separate issues that deserve separate consideration. One issue should not disqualify the debate over the other. We want all issues on the table. Decriminalization and harm reduction through criminal justice reform is the first step,” Bell said.

Georgia CARE Project focuses on three areas of reform: criminal justice, medicinal cannabis, and industrial hemp.